VGX-6150

· GeneOne Life Science, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VGX-6150, covering 2017-08-07 to 2017-08-07. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of VGX-6150 for Second-line Therapy of Chronic Hepatitis C Infection [Phase 1]

See pricing